These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

598 related articles for article (PubMed ID: 27248460)

  • 41. Risk Factors for Survival After Heart Transplantation in Children and Young Adults: A 22-Year Study of 179 Transplants.
    Shah S; Asante-Korang A; Ghazarian SR; Stapleton G; Herbert C; Decker J; Almodovar MC; Karl TR; Do NL; Quintessenza JA; Mavroudis C; Vricella LA; van Gelder HM; Kartha V; Alexander P; Carapellucci J; Krasnopero D; Hanson J; Amankwah E; Roth J; Jacobs JP
    World J Pediatr Congenit Heart Surg; 2018 Sep; 9(5):557-564. PubMed ID: 30157732
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Complications of left ventricular assist devices causing high urgency status on waiting list: impact on outcome after heart transplantation.
    Immohr MB; Boeken U; Mueller F; Prashovikj E; Morshuis M; Böttger C; Aubin H; Gummert J; Akhyari P; Lichtenberg A; Schramm R
    ESC Heart Fail; 2021 Apr; 8(2):1253-1262. PubMed ID: 33480186
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Outcomes with ventricular assist device versus extracorporeal membrane oxygenation as a bridge to pediatric heart transplantation.
    Jeewa A; Manlhiot C; McCrindle BW; Van Arsdell G; Humpl T; Dipchand AI
    Artif Organs; 2010 Dec; 34(12):1087-91. PubMed ID: 20545660
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of functional capacity in patients with end-stage heart failure following implantation of a left ventricular assist device versus heart transplantation: results of the experience with left ventricular assist device with exercise trial.
    Jaski BE; Lingle RJ; Kim J; Branch KR; Goldsmith R; Johnson MR; Lahpor JR; Icenogle TB; Piña I; Adamson R; Favrot LK; Dembitsky WP
    J Heart Lung Transplant; 1999 Nov; 18(11):1031-40. PubMed ID: 10598726
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation.
    Clegg AJ; Scott DA; Loveman E; Colquitt J; Hutchinson J; Royle P; Bryant J
    Health Technol Assess; 2005 Nov; 9(45):1-132, iii-iv. PubMed ID: 16303098
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of percutaneous veno-arterial extracorporeal membrane oxygenation as bridge to left ventricular assist device.
    Toda K; Fujita T; Seguchi O; Yanase M; Nakatani T
    J Artif Organs; 2018 Mar; 21(1):39-45. PubMed ID: 28871334
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Extracorporeal membrane oxygenation as a direct bridge to heart transplantation in adults.
    Fukuhara S; Takeda K; Kurlansky PA; Naka Y; Takayama H
    J Thorac Cardiovasc Surg; 2018 Apr; 155(4):1607-1618.e6. PubMed ID: 29361299
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Decade of Experience With Continuous-Flow Left Ventricular Assist Devices.
    John R; Holley CT; Eckman P; Roy SS; Cogswell R; Harvey L; Shumway S; Liao K
    Semin Thorac Cardiovasc Surg; 2016 Summer; 28(2):363-375. PubMed ID: 28043445
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Temporary right ventricular support following left ventricle assist device implantation: a comparison of two techniques.
    Noly PE; Kirsch M; Quessard A; Leger P; Pavie A; Amour J; Leprince P
    Interact Cardiovasc Thorac Surg; 2014 Jul; 19(1):49-55. PubMed ID: 24659551
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ventricular Assist Device Support as a Bridge to Transplantation in Pediatric Patients.
    Dipchand AI; Kirk R; Naftel DC; Pruitt E; Blume ED; Morrow R; Rosenthal D; Auerbach S; Richmond ME; Kirklin JK;
    J Am Coll Cardiol; 2018 Jul; 72(4):402-415. PubMed ID: 30025576
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Successful support of biventricular heart failure patients by new EXCOR
    Schmack B; Weymann A; Ruschitzka F; Autschbach R; Raake PW; Jurrmann N; Menon AK; Karck M; Wilhelm MJ; Ruhparwar A
    Clin Res Cardiol; 2018 May; 107(5):413-420. PubMed ID: 29294144
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Extracorporeal membrane oxygenation as a bridge to durable mechanical circulatory support or heart transplantation.
    Hansen B; Singer Englar T; Cole R; Catarino P; Chang D; Czer L; Emerson D; Geft D; Kobashigawa J; Megna D; Ramzy D; Moriguchi J; Esmailian F; Kittleson M
    Int J Artif Organs; 2022 Jul; 45(7):604-614. PubMed ID: 35658592
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Outcomes of pediatric patients bridged to heart transplantation from extracorporeal membrane oxygenation support.
    BarZiv SM; McCrindle BW; West LJ; Edgell D; Coles JG; VanArsdell GS; Bohn D; Perez R; Campbell A; Dipchand AI
    ASAIO J; 2007; 53(1):97-102. PubMed ID: 17237655
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Use of Extracorporeal Membrane Oxygenation as Bridge to Replacement Therapies in Cardiogenic Shock: Insights From the Extracorporeal Life Support Organization.
    Mastoris I; Tonna JE; Hu J; Sauer AJ; Haglund NA; Rycus P; Wang Y; Wallisch WJ; Abicht TO; Danter MR; Tedford RJ; Fang JC; Shah Z
    Circ Heart Fail; 2022 Jan; 15(1):e008777. PubMed ID: 34879706
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Outcomes after implantation of partial-support left ventricular assist devices in inotropic-dependent patients: Do we still need full-support assist devices?
    Sabashnikov A; Popov AF; Bowles CT; Mohite PN; Weymann A; Hards R; Hedger M; Wittwer T; Wippermann J; Wahlers T; Schoendube FA; Simon AR
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1115-21; discussion 1021-2. PubMed ID: 25129605
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Continuous-flow left ventricular assist device therapy in patients with preoperative hepatic failure: are we pushing the limits too far?
    Weymann A; Patil NP; Sabashnikov A; Mohite PN; Garcia Saez D; Bireta C; Wahlers T; Karck M; Kallenbach K; Ruhparwar A; Fatullayev J; Amrani M; De Robertis F; Bahrami T; Popov AF; Simon AR
    Artif Organs; 2015 Apr; 39(4):336-42. PubMed ID: 25345547
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bridging strategies and cardiac replacement outcomes in patients with acute decompensated heart failure-related cardiogenic shock.
    Varshney AS; Berg DD; Zhou G; Sinnenberg L; Hirji S; DeFilippis EM; Mallidi HR; Morrow DA; Rinewalt D; Givertz MM
    Eur J Heart Fail; 2023 Mar; 25(3):425-435. PubMed ID: 36597721
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prolonged continuous-flow left ventricular assist device support and posttransplantation outcomes: A new challenge.
    Fukuhara S; Takeda K; Polanco AR; Takayama H; Naka Y
    J Thorac Cardiovasc Surg; 2016 Mar; 151(3):872-880.e5. PubMed ID: 26896362
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Outcome of cardiac transplantation in patients requiring prolonged continuous-flow left ventricular assist device support.
    Takeda K; Takayama H; Kalesan B; Uriel N; Colombo PC; Jorde UP; Yuzefpolskaya M; Mancini DM; Naka Y
    J Heart Lung Transplant; 2015 Jan; 34(1):89-99. PubMed ID: 25444372
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of implantable cardioverter-defibrillators in patients with continuous flow left ventricular assist devices.
    Enriquez AD; Calenda B; Miller MA; Anyanwu AC; Pinney SP
    Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):668-74. PubMed ID: 23873139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.